These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 492854)

  • 1. [Tyrosine content in the blood as an index of the adequacy of glucocorticoid replacement therapy in congenital adrenal cortical dysfunction in children].
    Rass IT; Kuznetsova ES; Zhukovskiĭ MA
    Pediatriia; 1979 Sep; (9):26-9. PubMed ID: 492854
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression.
    Keenan BS; McNeel R; Barrett GN; Holcombe JH; Kirkland RT; Clayton GW
    J Lab Clin Med; 1979 Nov; 94(5):799-808. PubMed ID: 159330
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood tyrosine level in glucocorticoid therapy].
    Rass IT
    Lab Delo; 1981; (8):485-8. PubMed ID: 6168808
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of therapy on mature height in congenital adrenal hyperplasia.
    Kirkland RT; Keenan BS; Holcombe JH; Kirkland JL; Clayton GW
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1320-4. PubMed ID: 263352
    [No Abstract]   [Full Text] [Related]  

  • 5. Variable efficacy of glucocorticoids in congenital adrenal hyperplasia.
    Hansen JW; Loriaux DL
    Pediatrics; 1976 Jun; 57(6):942-7. PubMed ID: 934750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of glucocorticoids on potassium and sodium metabolism during the treatment of congenital dysfunction of the adrenal cortex].
    Kozlov GI
    Probl Endokrinol (Mosk); 1973; 19(1):32-4. PubMed ID: 4698452
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteocalcin in congenital adrenal hyperplasia.
    Lisá L; Neradilová M; Tomásová N; Soutorová M; Zimák J
    Bone; 1995 Jan; 16(1):57-9. PubMed ID: 7742084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
    Loras B; Roux H; Audi-Parera L; David M; Bertrand J
    Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
    [No Abstract]   [Full Text] [Related]  

  • 9. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency.
    Webb EA; Krone N
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):449-68. PubMed ID: 26051302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood progesterone and 17-hydroxyprogesterone levels and production rates in a boy with virilizing congenital adrenal hyperplasia.
    Strott CA; Yoshimi T; Bardin CW; Lipsett MB
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1085-8. PubMed ID: 5660261
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
    Sulcová J; Lisá L; Dvorák P; Hampl R; Stárka L
    Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A contribution to the therapy of the congenital adrenal hyperplasia (author's transl)].
    Gleispach H
    Wien Klin Wochenschr; 1974 Sep; 86(17):508-11. PubMed ID: 4408420
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment-induced hypoandrogenism in childhood and puberty in females with virilizing (21-hydroxylase deficiency) congenital adrenal hyperplasia.
    New MI
    J Endocrinol; 1996 Sep; 150 Suppl():S31-2. PubMed ID: 8943784
    [No Abstract]   [Full Text] [Related]  

  • 15. Temporal and individual variations in the dose of glucocorticoid used for the treatment of salt-losing congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency.
    Sandrini R; Jospe N; Migeon CJ
    Acta Paediatr Suppl; 1993 Mar; 388():56-60; discussion 61. PubMed ID: 8329832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patterns of growth in congenital adrenal hyperplasia. Correlation between glucocorticoid therapy and stature].
    Igea JM; Lóridan L; Martul P; Ferrández A; Mayayo E; Rodríguez M; Oyarzábal M; Elcarte R; Luzuriaga C
    An Esp Pediatr; 1988 Oct; 29 Suppl 35():9-12. PubMed ID: 3272842
    [No Abstract]   [Full Text] [Related]  

  • 17. Congenital adrenal hyperplasia: case report in dizygotic twins.
    Tze WJ; Fisher JN; Crigler JF
    Pediatrics; 1972 Jul; 50(1):137-9. PubMed ID: 5038089
    [No Abstract]   [Full Text] [Related]  

  • 18. Aldosterone secretion rate in the simple virilizing form of congenital adrenal hyperplasia.
    Dahl V; Rivarola MA; Bergadá C
    J Clin Endocrinol Metab; 1972 Apr; 34(4):661-5. PubMed ID: 4552020
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood testosterone values in patients with congenital virilizing adrenal hyperplasia.
    Solomon IL; Schoen EJ; Donelan L; Brandt-Erichsen D
    J Clin Endocrinol Metab; 1975 Mar; 40(3):355-62. PubMed ID: 163840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of congenital adrenal hyperplasia.
    Clayton BE
    Proc R Soc Med; 1970 Oct; 63(10):1042-4. PubMed ID: 5483505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.